CClinicalTrials.gg
CompletedNCT02148159Updated Jan 17, 2019

Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer

An interventional study of Cachexia Acupuncture-A (Peace Classic Needles® ) and General Acupuncture-B (Peace Classic Needles®) in Malignant Neoplasm of Gastrointestinal Tract, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2019-01-17.

Sponsored by University of Florida · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Patients with cancer often experience appetite loss and weight loss unintentionally. Rapid weight loss negatively impact on physical functioning, quality of life, and overall survival. Patients will be randomly assigned into two groups. An intervention with acupuncture may slow down or stop the progression of cancer-related anorexia and weight loss.

Read the detailed description

The purpose of this research study is to investigate if acupuncture helps to improve appetite and slow down unintentional weight loss. The participants will be randomly divided into two groups and receive 8 sessions of acupuncture (two groups will receive different acupuncture points) for 8 weeks. During the study period, participants will be asked various questions about appetite, physical functioning, cancer-related symptoms and quality of life to understand changes related to body weight, as well as blood samples. The research team members will collect data regarding changes in appetite, body weight, body composition, and physical functioning.

02

Conditions studied

  • Malignant Neoplasm of Gastrointestinal Tract

Keywords

  • anorexia
  • cachexia
  • cancer
  • unintentional weigh loss
  • gastrointestinal tract
  • adults
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 45 is close to the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 21 year or older
  • medical diagnosis of gastrointestinal cancer (for example, gastric, biliary, or colorectal)
  • experienced weight loss of at least 5% over the last 6 months
  • ability to communicate in English
  • ability to follow the research protocol

Exclusion criteria

Exclusion Criteria:

  • plan to have surgical procedures at the time of recruitment
  • receive radiation therapy alone or in addition to chemotherapy during the study period
  • undergo surgery during the study or in the months prior to the study
  • no plan to have chemotherapy after the surgery
  • any comorbidities that may affect the interpretation of study findings
  • open burn sites or infected wounds
  • esophageal cancer or pancreatic cancer
  • life expectancy of less than 6 months as assessed by attending physician
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Cachexia Acupuncture-A

    Acupuncture-A group will receive acupuncture in a pre-determined set of the acupuncture points that are selected based on the potential mechanisms of cachexia. Intervention will be done by a licensed acupuncturist who has over 5 years of experience as an independent clinician and has experience particularly in the management of cancer related symptoms. Acupuncture treatment will consist of 8 sessions over 8 week period. Acupuncture needles: Single-use, sterile stainless steel and disposable \[acupuncture needles-Peace Classic Needles®, Acu-Market\] Other name: Mechanism based acupuncture

    Device: Cachexia Acupuncture-A (Peace Classic Needles® )

  • Sham comparator
    General Acupuncture-B

    General Acupuncture-B group will receive acupuncture in a pre-determined set of the acupuncture points. These points are the real acupuncture points; however, these points are not specific to cachexia management. Participants will receive the acupuncture treatment over 8 weeks (total of 8 sessions) in the same manner as the experimental group; the only difference will be the place(type) and number of points targeted. Acupuncture needles: single-use, sterile stainless steel and disposable needles \[Peace Classic Needles®, Acu-Market\] Other name: General acupuncture

    Device: General Acupuncture-B (Peace Classic Needles®)

Interventions

  • DeviceCachexia Acupuncture-A (Peace Classic Needles® )

    Acupuncture-A group will receive acupuncture in a pre-determined set of the acupuncture points.

    Also known as: Acu-Market, Mechanism based acupuncture

  • DeviceGeneral Acupuncture-B (Peace Classic Needles®)

    Acupuncture-B group will receive acupuncture in a pre-determined set of the acupuncture points.

    Also known as: Acu-Market, General acupuncture

06

What researchers measure

Primary outcomes

  1. Percentage weight change over 8 weeks between two arms

    Weight will be measured each visit (pounds).

    Time frame: up to 8 weeks

Secondary outcomes

  1. Appetite change between two arms

    Three different short survey forms will be used to measure appetite change. Visual analogue scale (0 indicates no appetite and 10 is the best appetite). Simplified Nutritional Appetite Questionnaire score (min-max: 4-20 and the higher the better appetite) Patient Generated Subjective Global Assessment: 0-1, no intervention is needed. 9 or higher score indicates critical intervention.

    Time frame: up to 8 weeks

  2. physical functioning

    survey form (min-max: 0-100, increment by 10%- 100% indicates full functioning).

    Time frame: up to 8 weeks

  3. body composition

    Small, non-invasive device (bioelectrical impedance analysis) like a miniature version of EKG will measure changes in body composition (numeric scale).

    Time frame: up to 8 weeks

Other outcomes

  1. Quality of life between two arms

    Survey format includes the 27 items (5 points scale: 0 means 'not at all' and 4 means 'very much") .

    Time frame: up to 8 weeks

  2. biomarkers

    Small amounts of blood will be drawn.

    Time frame: weeks 1, 4 and 8 (three measurements)

  3. symptom experience

    Survey format: 13 areas related to the symptom experience and patient's concerns will be assessed (4 points scale; 0 means 'not at all' and 3 means 'very much').

    Time frame: up to 8 weeks

07

Study locations

1 site
  • University of Florida Clinical Research Center (CRC)
    Gainesville, Florida 32610-0219, United States
08

References and documents

Publications

  • Yoon SL, Grundmann O, Williams JJ, Gordan L, George TJ Jr. Body composition changes differ by gender in stomach, colorectal, and biliary cancer patients with cachexia: Results from a pilot study. Cancer Med. 2018 Aug;7(8):3695-3703. doi: 10.1002/cam4.1665. Epub 2018 Jul 3. PubMed 29971962 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02148159
Lead sponsor
University of Florida
Responsible party
Sponsor
First posted
May 28, 2014
Start date
Oct 2014
Primary completion
May 2016
Completion
May 2016
Last update
Jan 17, 2019

Study contacts

Saunjoo Yoon, PhD
principal investigator · University of Florida

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion